Načítá se...
Clostridium difficile Infection and Fecal Microbiota Transplant
Clostridium difficile infection (CDI) is a major source of morbidity and mortality for hospitalized patients. Although most patients have a clinical response to existing antimicrobial therapies, recurrent infection develops in up to 30% of patients. Fecal microbiota transplant is a novel approach to...
Uloženo v:
| Vydáno v: | AACN Adv Crit Care |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5666691/ https://ncbi.nlm.nih.gov/pubmed/27959316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4037/aacnacc2016703 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|